tyloxapol has been researched along with Innate Inflammatory Response in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, H; Jin, M; Qin, H; Wang, Q; Wei, Y; Yan, S; Zhang, D; Zhao, L; Zheng, L | 1 |
| Cheng, J; Feng, H; Jin, M; Li, Z; Liu, G; Qin, H; Shen, B; Wang, Q; Zhao, L | 1 |
| Cheng, L; Guo, M; He, Y; Jiang, H; Liu, J; Ren, C; Shi, Y; Sun, M; Wang, B; Wang, W; Wang, X; Xie, Y; Xu, X | 1 |
| Chi, G; Feng, H; Han, L; Li, Z; Shen, B; Tian, Y; Wang, Y; Wu, L; Zhang, Q | 1 |
| Feng, H; Li, Y; Li, Z; Shen, B; Shi, L; Tian, Y; Zhao, C | 1 |
| Eschenburg, C; Koppitz, M; Rosewich, M; Salzmann, E; Schubert, R; Zielen, S | 1 |
| Coutinho, HDM; de Alencar Menezes, IR; de Barros Viana, GS; de Figueiredo, PRL; de Oliveira, JA; Felipe, CFB; Kerntopf, MR; Leal, LKAM; Neto, JBS; Oliveira, IB; Ribeiro, LB; Rocha, TM | 1 |
1 trial(s) available for tyloxapol and Innate Inflammatory Response
| Article | Year |
|---|---|
Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.
Topics: Administration, Inhalation; Aged; Double-Blind Method; Expectorants; Female; Forced Expiratory Volume; Humans; Inflammation; Male; Middle Aged; Polyethylene Glycols; Pulmonary Disease, Chronic Obstructive; Sputum; Treatment Outcome | 2016 |
6 other study(ies) available for tyloxapol and Innate Inflammatory Response
| Article | Year |
|---|---|
Lipopolysaccharide and tyloxapol accelerate the development of atherosclerosis in mice.
Topics: Animals; Atherosclerosis; Hypercholesterolemia; Hyperlipidemias; Inflammation; Lipid Metabolism; Lipopolysaccharides; Liver; Mice; Polyethylene Glycols; Triglycerides | 2022 |
Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways.
Topics: AMP-Activated Protein Kinases; Animals; Gene Expression Regulation; Hep G2 Cells; Humans; Inflammation; Iridoids; Lipids; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Palmitic Acid; Phosphatidylinositol 3-Kinases; Phosphorylation; Polyethylene Glycols; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
The combination of sesamol and clofibric acid moieties leads to a novel potent hypolipidemic agent with antioxidant, anti-inflammatory and hepatoprotective activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Benzodioxoles; Clofibric Acid; Dose-Response Relationship, Drug; Hyperlipidemias; Hypolipidemic Agents; Inflammation; Liver; Mice; Mice, Inbred Strains; Molecular Docking Simulation; Molecular Structure; Oxidative Stress; Phenols; Polyethylene Glycols; Protective Agents; Structure-Activity Relationship | 2021 |
Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinase Kinases; Animals; Flavonoids; Hep G2 Cells; Hepatocytes; Humans; Hyperlipidemias; Inflammation; Lipid Metabolism; Mice; Non-alcoholic Fatty Liver Disease; Oleic Acid; Phosphorylation; Polyethylene Glycols; PPAR alpha; Protein Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2019 |
Loganin inhibits the inflammatory response in mouse 3T3L1 adipocytes and mouse model.
Topics: 3T3 Cells; Adipocytes; Animals; Anti-Inflammatory Agents; Atherosclerosis; Chemokine CCL2; Disease Models, Animal; Humans; Inflammation; Interleukin-6; Iridoids; Lipid Metabolism; Mice; NF-kappa B; Phosphorylation; Polyethylene Glycols; Signal Transduction; Tumor Necrosis Factor-alpha | 2016 |
Caryocar coriaceum Wittm. (Pequi) fixed oil presents hypolipemic and anti-inflammatory effects in vivo and in vitro.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Carrageenan; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Dyslipidemias; Ericales; Fruit; Humans; Hypolipidemic Agents; Inflammation; Lipids; Neutrophils; Peroxidase; Phytotherapy; Plant Extracts; Plant Oils; Plants, Medicinal; Polyethylene Glycols; Rats, Wistar; Time Factors | 2016 |